THERAPY OF CHRONIC MYELOID-LEUKEMIA - PRO GNOSTIC CRITERIA

Most informative, practicable clinical, morphological and histomorphol ogical criteria have been identified characterizing the stage of clini cal evolution of chronic myeloid leukemia (CML) by the time of its dia gnosis. Such criteria can be utilized for featuring the risk of short- and long-term CML aggravation. The patients at risk of the disease ac celeration are recognized, the survival for various risk groups is ana lyzed. By a complex of significant signs the patients may be diagnosti cally classified as being at standard, moderate and high risk.